{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:30:52Z","timestamp":1792438252836,"version":"4.5.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jgeb.2025.100616","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T04:52:19Z","timestamp":1764391939000},"page":"100616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Transcriptomics analysis unveils the complex interplay between diabetes and hypertension in regulating renal cell carcinoma pathway followed by pancreatic metastasis"],"prefix":"10.1016","volume":"23","author":[{"given":"K.M. Tanjida","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roksana","family":"Khanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3586-9251","authenticated-orcid":false,"given":"Aninda","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramisa Binti","family":"Mohiuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannati","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh Abdullah","family":"Al Ashik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2380-1953","authenticated-orcid":false,"given":"Saborni","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.M.","family":"Mohiuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-2527","authenticated-orcid":false,"given":"Shahin","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jgeb.2025.100616_b0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41581-023-00700-5","article-title":"Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigens","volume":"19","author":"Wolf","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"10.1016\/j.jgeb.2025.100616_b0010","first-page":"253","article-title":"Immunotherapy in renal cell carcinoma: the future is now","volume":"21","author":"Deleuze","year":"2020","journal-title":"Int J Mole Sci"},{"issue":"4","key":"10.1016\/j.jgeb.2025.100616_b0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41571-020-00455-z","article-title":"Beyond conventional immune-checkpoint inhibition \u2014 novel immunotherapies for renal cell carcinoma","volume":"18","author":"Braun","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1016\/j.jgeb.2025.100616_b0020","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/biomedicines11041071","article-title":"Immune checkpoint inhibitors in renal cell carcinoma: molecular basis and rationale for their use in clinical practice","volume":"11","author":"Lasorsa","year":"2023","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.jgeb.2025.100616_b0025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41581-020-0316-3","article-title":"The immunology of renal cell carcinoma","volume":"16","author":"D\u00edaz-Montero","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.jgeb.2025.100616_b0030","first-page":"584","article-title":"The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years after","volume":"161","author":"Bassi","year":"2017","journal-title":"Surgery (United States)"},{"issue":"8","key":"10.1016\/j.jgeb.2025.100616_b0035","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/annonc\/mdu191","article-title":"Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients","volume":"25","author":"Ali","year":"2014","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.jgeb.2025.100616_b0040","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1053\/j.gastro.2007.03.102","article-title":"Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients","volume":"132","author":"Fu","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-065X.2008.00614.x","article-title":"The impact of T-cell immunity on ovarian cancer outcomes","volume":"222","author":"Nelson","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jgeb.2025.100616_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.810262","article-title":"Risk factors for the comorbidity of hypertension and renal cell carcinoma in the cardio-oncologic era and treatment for tumor-induced hypertension","volume":"9","author":"Ba","year":"2022","journal-title":"Front Cardiovasc Med."},{"issue":"16","key":"10.1016\/j.jgeb.2025.100616_b0055","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.3390\/ijms25169060","article-title":"Advances in molecular mechanisms of kidney disease: integrating renal tumorigenesis of hereditary cancer syndrome","volume":"25","author":"Cicchetti","year":"2024","journal-title":"Int J Mole Sci"},{"issue":"4","key":"10.1016\/j.jgeb.2025.100616_b0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41581-023-00800-2","article-title":"Metabolic alterations in hereditary and sporadic renal cell carcinoma","volume":"20","author":"Coffey","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-69302-w","article-title":"Bioinformatics analysis to disclose shared molecular mechanisms between type-2 diabetes and clear-cell renal-cell carcinoma, and therapeutic indications","volume":"14","author":"Ahmmed","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgeb.2025.100616_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110708","article-title":"Type II diabetes mellitus: a review on recent drug based therapeutics","volume":"131","author":"Padhi","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"10365","key":"10.1016\/j.jgeb.2025.100616_b0075","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","article-title":"Type 2 diabetes","volume":"400","author":"Ahmad","year":"2022","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0080","first-page":"1","article-title":"Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy","volume":"9","author":"Lu","year":"2024","journal-title":"Signal Transduct Target Therapy"},{"key":"10.1016\/j.jgeb.2025.100616_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1173402","article-title":"Inflammation, oxidative stress and mitochondrial dysfunction in the progression of type II diabetes mellitus with coexisting hypertension","volume":"14","author":"Yousef","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"10.1016\/j.jgeb.2025.100616_b0090","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.3390\/ijms24108629","article-title":"Potential role of the mTORC1-PGC1\u03b1-PPAR\u03b1 axis under type-II diabetes and hypertension in the human heart","volume":"24","author":"Hang","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ahj.2004.07.013","article-title":"Metabolic syndrome: definition, pathophysiology, and mechanisms","volume":"149","author":"Miranda","year":"2005","journal-title":"Am Heart J."},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0100","first-page":"1","article-title":"Metabolic syndrome","volume":"10","author":"Neeland","year":"2024","journal-title":"Nat Rev Disease Prim"},{"issue":"4","key":"10.1016\/j.jgeb.2025.100616_b0105","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.3390\/ijms25042251","article-title":"The metabolic syndrome, a human disease","volume":"25","author":"Alemany","year":"2024","journal-title":"Int J Mole Sci"},{"issue":"6","key":"10.1016\/j.jgeb.2025.100616_b0110","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.3390\/ijms25063086","article-title":"Recent advances in the management of diabetic kidney disease: slowing progression","volume":"25","author":"Lione","year":"2024","journal-title":"Int J Mole Sci"},{"issue":"3","key":"10.1016\/j.jgeb.2025.100616_b0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41581-019-0210-z","article-title":"Oncometabolites in renal cancer","volume":"16","author":"Yong","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"10.1016\/j.jgeb.2025.100616_b0120","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/j.1464-410X.2011.10254.x","article-title":"How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis","volume":"108","author":"Abouassaly","year":"2011","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.jgeb.2025.100616_b0125","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3892\/ijmm.2016.2776","article-title":"Mechanisms through which diabetes mellitus influences renal cell carcinoma development and treatment: a review of the literature","volume":"38","author":"Labochka","year":"2016","journal-title":"Int J Mol Med"},{"issue":"11","key":"10.1016\/j.jgeb.2025.100616_b0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41585-023-00781-8","article-title":"Effect of smoking, hypertension and lifestyle factors on kidney cancer\u2014perspectives for prevention and screening programmes","volume":"20","author":"Campi","year":"2023","journal-title":"Nat Rev Urol"},{"issue":"6","key":"10.1016\/j.jgeb.2025.100616_b0135","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/HYPERTENSIONAHA.120.14820","article-title":"Association of hypertension and blood pressure with kidney cancer risk: a nationwide population-based cohort study","volume":"75","author":"Kim","year":"2020","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.jgeb.2025.100616_b0140","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.3390\/jcm12113656","article-title":"Impact of smoking, body weight, diabetes, hypertension and kidney dysfunction on survival in pancreatic cancer patients\u2014a single center analysis of 2323 patients within the last decade","volume":"12","author":"Neumann","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jgeb.2025.100616_b0145","first-page":"OF1","article-title":"The relationship between diabetes mellitus and pancreatic cancer\u2014diabetes mellitus as a red flag for pancreatic cancer","author":"Popovic","year":"2023","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"4","key":"10.1016\/j.jgeb.2025.100616_b0150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.hpb.2019.10.017","article-title":"Pancreatic resection for metastatic renal cell carcinoma. A systematic review","volume":"22","author":"Jaen-Torrejimeno","year":"2020","journal-title":"Hpb"},{"issue":"43","key":"10.1016\/j.jgeb.2025.100616_b0155","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.3748\/wjg.v17.i43.4747","article-title":"Pancreatic metastases from renal cell carcinoma: the state of the art","volume":"17","author":"Ballarin","year":"2011","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.jgeb.2025.100616_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7819-11-289","article-title":"Pancreatic metastases from renal cell carcinoma: a case report and literature review of the clinical and radiological characteristics","volume":"11","author":"Hoshino","year":"2013","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pan.2023.11.014","article-title":"Pancreatic resection for metastasis from renal cell carcinoma: a single institution experience and meta-analysis of survival outcomes","volume":"24","author":"Hajibandeh","year":"2024","journal-title":"Pancreatology"},{"key":"10.1016\/j.jgeb.2025.100616_b0170","article-title":"Case report: pancreatic metastasis from small-cell lung cancer appears as primary G2 pancreatic neuroendocrine tumor on combined contrast PET imaging with three probes","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.jgeb.2025.100616_b0175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10585-020-10029-z","article-title":"Curative-intent pancreas resection for pancreatic metastases: surgical and oncological results","volume":"37","author":"Chikhladze","year":"2020","journal-title":"Clin Exp Metast"},{"key":"10.1016\/j.jgeb.2025.100616_b0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.70470\/SHIFAA\/2023\/007","article-title":"Epigenetic modifications as predictive biomarkers for cardiovascular disease: a longitudinal study on DNA methylation patterns and disease risk","volume":"2023","author":"Burhanuddin","year":"2023","journal-title":"SHIFAA"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41688","article-title":"Computational network analysis of two popular skin cancers provides insights into the molecular mechanisms and reveals common therapeutic targets","volume":"11","author":"Mahmud","year":"2025","journal-title":"Heliyon"},{"issue":"D1","key":"10.1016\/j.jgeb.2025.100616_b0190","doi-asserted-by":"crossref","first-page":"D138","DOI":"10.1093\/nar\/gkad965","article-title":"NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update","volume":"52","author":"Clough","year":"2024","journal-title":"Nucl Acids Res"},{"issue":"14","key":"10.1016\/j.jgeb.2025.100616_b0195","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor","volume":"23","author":"Sean","year":"2007","journal-title":"Bioinformatics."},{"issue":"7","key":"10.1016\/j.jgeb.2025.100616_b0200","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucl Acids Res"},{"issue":"10","key":"10.1016\/j.jgeb.2025.100616_b0205","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/ard-2024-225537","article-title":"Adjustment of p values for multiple hypotheses: why, when and how","volume":"83","author":"Lydersen","year":"2024","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr Protoc Bioinform"},{"issue":"D1","key":"10.1016\/j.jgeb.2025.100616_b0215","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2020","journal-title":"Nucl Acids Res"},{"issue":"7","key":"10.1016\/j.jgeb.2025.100616_b0220","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41576-023-00574-0","article-title":"Mendelian inheritance revisited: dominance and recessiveness in medical genetics","volume":"24","author":"Zschocke","year":"2023","journal-title":"Nat Rev Gene"},{"key":"10.1016\/j.jgeb.2025.100616_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-015-0611-3","article-title":"InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams","volume":"16","author":"Heberle","year":"2015","journal-title":"BMC Bioinform"},{"issue":"D1","key":"10.1016\/j.jgeb.2025.100616_b0230","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucl Acids Res"},{"issue":"10","key":"10.1016\/j.jgeb.2025.100616_b0235","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/nprot.2007.324","article-title":"Integration of biological networks and gene expression data using Cytoscape","volume":"2","author":"Cline","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jgeb.2025.100616_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"issue":"11","key":"10.1016\/j.jgeb.2025.100616_b0245","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nmeth.2212","article-title":"A travel guide to Cytoscape plugins","volume":"9","author":"Saito","year":"2012","journal-title":"Nat Methods"},{"issue":"D1","key":"10.1016\/j.jgeb.2025.100616_b0250","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucl Acids Res"},{"issue":"W1","key":"10.1016\/j.jgeb.2025.100616_b0255","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucl Acids Res"},{"issue":"11","key":"10.1016\/j.jgeb.2025.100616_b0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"issue":"W1","key":"10.1016\/j.jgeb.2025.100616_b0265","doi-asserted-by":"crossref","first-page":"W234","DOI":"10.1093\/nar\/gkz240","article-title":"NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucl Acids Res"},{"issue":"W1","key":"10.1016\/j.jgeb.2025.100616_b0270","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucl Acids Res"},{"issue":"D1","key":"10.1016\/j.jgeb.2025.100616_b0275","doi-asserted-by":"crossref","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","article-title":"TTD: Therapeutic Target Database describing target druggability information","volume":"52","author":"Zhou","year":"2024","journal-title":"Nucl Acids Res."},{"issue":"D1","key":"10.1016\/j.jgeb.2025.100616_b0280","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"Drugbank 6.0: the drugbank knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucl Acids Res"},{"issue":"D1","key":"10.1016\/j.jgeb.2025.100616_b0285","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.jgeb.2025.100616_b0290","article-title":"Flexible ligand docking with glide","volume":"18(1)","author":"Repasky","year":"2007","journal-title":"Curr Protoc Bioinform"},{"issue":"7","key":"10.1016\/j.jgeb.2025.100616_b0295","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-025-18547-0","article-title":"In silico approaches unveil the mechanism of action of Eclipta prostrata against acute myeloid leukemia","volume":"15","author":"Islam","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.nexres.2024.100012","article-title":"Integrating computational 3D-QSAR and pharmacophore modelling in diverse natural phytochemicals library for targeted therapy against breast cancer estrogen receptors","volume":"1","author":"Islam","year":"2024","journal-title":"Next Res"},{"issue":"D1","key":"10.1016\/j.jgeb.2025.100616_b0310","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","author":"Gilson","year":"2016","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.jgeb.2025.100616_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107481","article-title":"Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: an in silico perspective for the identification of new potential HDAC3 inhibitors","volume":"166","author":"Lanka","year":"2023","journal-title":"Comput Biol Med."},{"key":"10.1016\/j.jgeb.2025.100616_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.csbr.2024.100021","article-title":"Ligand-based pharmacophore modeling targeting the fluoroquinolone antibiotics to identify potential antimicrobial compounds","volume":"1","author":"Ananna","year":"2024","journal-title":"Comput Struct Biotechnol Rep"},{"key":"10.1016\/j.jgeb.2025.100616_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.146985","article-title":"Network and pharmacophore guided and BCL2 and HSP90AA1 targeted drug repurposable approaches against rheumatoid arthritis mediated diffuse large B-cell lymphoma","volume":"325","author":"Islam","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jgeb.2025.100616_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.109727","article-title":"Pharmacophore-guided computational modeling of quinolone-ATPase conjugate inhibitors targeting DNA GyrB subunit of Staphylococcus aureus","volume":"186","author":"Al Amin","year":"2025","journal-title":"Comput Biol Med"},{"issue":"15","key":"10.1016\/j.jgeb.2025.100616_b0335","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70074","article-title":"Structure-based pharmacophore modeling for precision inhibition of mutant ESR2 in breast cancer: a systematic computational approach","volume":"13","author":"Islam","year":"2024","journal-title":"Cancer Med"},{"issue":"W1","key":"10.1016\/j.jgeb.2025.100616_b0340","doi-asserted-by":"crossref","first-page":"W442","DOI":"10.1093\/nar\/gkw287","article-title":"Pharmit: interactive exploration of chemical space","volume":"44","author":"Sunseri","year":"2016","journal-title":"Nucl Acids Res."},{"issue":"7","key":"10.1016\/j.jgeb.2025.100616_b0345","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: a free tool to discover chemistry for biology","volume":"52","author":"Irwin","year":"2012","journal-title":"J Chem Inf Model."},{"issue":"D1","key":"10.1016\/j.jgeb.2025.100616_b0350","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucl Acids Res."},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0355","first-page":"1","article-title":"a public web service for drug discovery","volume":"4","author":"Kiss","year":"2012","journal-title":"J Cheminform"},{"issue":"1\u20133","key":"10.1016\/j.jgeb.2025.100616_b0360","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","article-title":"GROMACS: a message-passing parallel molecular dynamics implementation","volume":"91","author":"Berendsen","year":"1995","journal-title":"Comput Phys Commun."},{"issue":"5","key":"10.1016\/j.jgeb.2025.100616_b0365","doi-asserted-by":"crossref","DOI":"10.1063\/5.0213317","article-title":"Quantum chemical package Jaguar: a survey of recent developments and unique features","volume":"161","author":"Cao","year":"2024","journal-title":"J Chem Phys"},{"issue":"31","key":"10.1016\/j.jgeb.2025.100616_b0370","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1002\/chem.201001051","article-title":"Proaromaticity: organic charge\u2010transfer chromophores with small HOMO\u2013LUMO gaps","volume":"16","author":"Wu","year":"2010","journal-title":"Chem\u2013A Euro J"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0375","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"issue":"W1","key":"10.1016\/j.jgeb.2025.100616_b0380","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucl Acids Res"},{"issue":"21","key":"10.1016\/j.jgeb.2025.100616_b0385","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res"},{"issue":"269","key":"10.1016\/j.jgeb.2025.100616_b0390","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"14_Supplement","key":"10.1016\/j.jgeb.2025.100616_b0395","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1158\/1538-7445.AM2016-5277","article-title":"Abstract 5277: the cBioPortal for cancer genomics and its application in precision oncology","volume":"76","author":"Gao","year":"2016","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.jgeb.2025.100616_b0400","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrclinonc.2012.156","article-title":"From drug discovery to biomarker-driven clinical trials in lymphoma","volume":"9","author":"Younes","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.jgeb.2025.100616_b0405","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrclinonc.2012.48","article-title":"Molecular prescreening to select patient population in early clinical trials","volume":"9","author":"Rod\u00f3n","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jgeb.2025.100616_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111073","article-title":"A comprehensive review on phosphatidylinositol-3-kinase (PI3K) and its inhibitors bearing pyrazole or indazole core for cancer therapy","volume":"398","author":"Bastos","year":"2024","journal-title":"Chem Biol Interact"},{"issue":"12","key":"10.1016\/j.jgeb.2025.100616_b0415","doi-asserted-by":"crossref","first-page":"7670","DOI":"10.1021\/acs.jmedchem.3c00028","article-title":"Targeting MET: discovery of small molecule inhibitors as non-small cell lung cancer therapy","volume":"66","author":"Wang","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.jgeb.2025.100616_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116771","article-title":"Structural insights into small-molecule KRAS inhibitors for targeting KRAS mutant cancers","volume":"277","author":"Pandey","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"21","key":"10.1016\/j.jgeb.2025.100616_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39677","article-title":"TNO155 is a selective SHP2 inhibitor to target PTPN11-dependent oral squamous cell carcinoma","volume":"10","author":"Chai","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.jgeb.2025.100616_b0430","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaci.2021.03.029","article-title":"Targeted inhibition of EPAS1-driven IL-31 production by a small-molecule compound","volume":"148","author":"Kamikaseda","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.jgeb.2025.100616_b0435","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s40265-020-01317-9","article-title":"Tepotinib: first approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.jgeb.2025.100616_b0440","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s40265-015-0431-9","article-title":"Trelagliptin: first global approval","volume":"75","author":"McKeage","year":"2015","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.jgeb.2025.100616_b0445","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1634\/theoncologist.2012-0044","article-title":"FDA approval summary: sunitinib for the treatment of progressive well-differentiated locally advanced or metastatic pancreatic neuroendocrine tumors","volume":"17","author":"Blumenthal","year":"2012","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0450","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1517\/14740338.2014.971008","article-title":"Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation","volume":"14","author":"Barnett","year":"2015","journal-title":"Exp Opin Drug Saf"},{"issue":"5","key":"10.1016\/j.jgeb.2025.100616_b0455","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4093\/dmj.2016.40.5.339","article-title":"Gemigliptin: an update of its clinical use in the management of type 2 diabetes mellitus","volume":"40","author":"Kim","year":"2016","journal-title":"Diabetes Metab J"},{"issue":"2","key":"10.1016\/j.jgeb.2025.100616_b0460","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-8227(01)00286-8","article-title":"Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patients","volume":"55","author":"Vichayanrat","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.jgeb.2025.100616_b0465","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40265-014-0199-3","article-title":"Vildagliptin: a review of its use in type 2 diabetes mellitus","volume":"74","author":"Keating","year":"2014","journal-title":"Drugs"},{"issue":"19","key":"10.1016\/j.jgeb.2025.100616_b0470","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1158\/1078-0432.CCR-22-0873","article-title":"FDA approval summary: cabozantinib for differentiated thyroid cancer","volume":"28","author":"Duke","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.jgeb.2025.100616_b0475","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.clnu.2020.07.028","article-title":"Assessment of adverse reactions to \u03b1-lipoic acid containing dietary supplements through spontaneous reporting systems","volume":"40","author":"Gatti","year":"2021","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100616_b0480","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/ERC-19-0263","article-title":"Neoplastic metastases to the endocrine glands","volume":"27","author":"Angelousi","year":"2020","journal-title":"Endocr Relat Cancer."},{"issue":"2","key":"10.1016\/j.jgeb.2025.100616_b0485","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/cancers15020339","article-title":"Isolated pancreatic metastases of renal cell carcinoma\u2014clinical particularities and seed and soil hypothesis","volume":"15","author":"Sellner","year":"2023","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.jgeb.2025.100616_b0490","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3390\/cancers14061539","article-title":"Isolated pancreatic metastases of renal cell cancer: genetics and epigenetics of an unusual tumour entity","volume":"14","author":"Sellner","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jgeb.2025.100616_b0495","unstructured":"Werner T. Impact of Type 2 Diabetes Mellitus on Renal Cell Carcinoma Prognosis. Published online; 2021."},{"key":"10.1016\/j.jgeb.2025.100616_b0500","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.compbiomed.2014.04.023","article-title":"Revealing pathway maps of renal cell carcinoma by gene expression change","volume":"51","author":"Hung","year":"2014","journal-title":"Comput Biol Med"},{"issue":"4","key":"10.1016\/j.jgeb.2025.100616_b0505","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2020","journal-title":"Cell Mole Immunol"},{"key":"10.1016\/j.jgeb.2025.100616_b0510","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.702726","article-title":"Regulatory T cells: barriers of immune infiltration into the tumor microenvironment","volume":"12","author":"Scott","year":"2021","journal-title":"Front Immunol"},{"issue":"16","key":"10.1016\/j.jgeb.2025.100616_b0515","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.3390\/cancers14163862","article-title":"A paradoxical role for regulatory T cells in the tumor microenvironment of pancreatic cancer","volume":"14","author":"Brouwer","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.jgeb.2025.100616_b0520","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3390\/cancers12082274","article-title":"Mechanisms of T-Cell exhaustion in pancreatic cancer","volume":"12","author":"Saka","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jgeb.2025.100616_b0525","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.csbj.2022.01.026","article-title":"Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants","volume":"20","author":"Yin","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.jgeb.2025.100616_b0530","first-page":"105","article-title":"Clinical data analysis using machine learning algorithms to predict the progression of type 2 diabetes","volume":"2025","author":"Syrou","year":"2025","journal-title":"Mesopot J Artif Intell Healthcare"},{"key":"10.1016\/j.jgeb.2025.100616_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.109754","article-title":"In-silico exploring pathway and mechanism-based therapeutics for allergic rhinitis: Network pharmacology, molecular docking, ADMET, quantum chemistry and machine learning based QSAR approaches","volume":"187","author":"Islam","year":"2025","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.jgeb.2025.100616_b0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.110441","article-title":"Computer-aided unveiling molecular mechanisms of Xylocarpus granatum against colorectal cancer: therapeutic intervention targeting P13K-AKT signaling pathway","volume":"193","author":"Ahamed","year":"2025","journal-title":"Comput Biol Med"},{"issue":"24","key":"10.1016\/j.jgeb.2025.100616_b0545","doi-asserted-by":"crossref","first-page":"22407","DOI":"10.1002\/cam4.6772","article-title":"Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer","volume":"12","author":"Reza","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.jgeb.2025.100616_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.109663","article-title":"Designing siRNA for silencing the human ERBB2 gene in cancer treatment: evaluating intracellular delivery strategies","volume":"186","author":"Mohiuddin","year":"2025","journal-title":"Comput Biol Med"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X2500160X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X2500160X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:57:31Z","timestamp":1778824651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X2500160X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1687157X2500160X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2025.100616","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptomics analysis unveils the complex interplay between diabetes and hypertension in regulating renal cell carcinoma pathway followed by pancreatic metastasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2025.100616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100616"}}